vs
CorMedix Inc.（CRMD）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
CorMedix Inc.的季度营收约是RESOURCES CONNECTION, INC.的1.1倍（$128.6M vs $117.7M），CorMedix Inc.自由现金流更多（$92.7M vs $15.6M）
CorMedix Inc.是一家处于商业阶段的生物制药企业，专注于开发及商业化用于预防和治疗感染性、炎症性及心肾疾病的创新治疗产品，核心管线针对导管相关血流感染，主要服务北美、欧洲的重症监护及长期透析患者群体。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
CRMD vs RGP — 直观对比
营收规模更大
CRMD
是对方的1.1倍
$117.7M
自由现金流更多
CRMD
多$77.2M
$15.6M
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $128.6M | $117.7M |
| 净利润 | — | $-12.7M |
| 毛利率 | 83.4% | 37.1% |
| 营业利润率 | 46.0% | -10.3% |
| 净利率 | — | -10.8% |
| 营收同比 | — | -19.2% |
| 净利润同比 | — | 81.6% |
| 每股收益（稀释后） | $0.20 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRMDRGP
| Q4 25 | $128.6M | $117.7M | ||
| Q3 25 | $104.3M | $120.2M | ||
| Q2 25 | $39.7M | $139.3M | ||
| Q1 25 | $39.1M | $129.4M | ||
| Q4 24 | — | $145.6M | ||
| Q3 24 | — | $136.9M | ||
| Q2 24 | — | $148.2M | ||
| Q1 24 | — | $151.3M |
净利润CRMDRGP
| Q4 25 | — | $-12.7M | ||
| Q3 25 | $108.6M | $-2.4M | ||
| Q2 25 | $19.8M | $-73.3M | ||
| Q1 25 | $20.6M | $-44.1M | ||
| Q4 24 | — | $-68.7M | ||
| Q3 24 | — | $-5.7M | ||
| Q2 24 | — | $10.5M | ||
| Q1 24 | — | $2.5M |
毛利率CRMDRGP
| Q4 25 | 83.4% | 37.1% | ||
| Q3 25 | 89.3% | 39.5% | ||
| Q2 25 | 95.3% | 40.2% | ||
| Q1 25 | 95.9% | 35.1% | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | — | 36.5% | ||
| Q2 24 | — | 40.2% | ||
| Q1 24 | — | 37.0% |
营业利润率CRMDRGP
| Q4 25 | 46.0% | -10.3% | ||
| Q3 25 | 49.2% | -1.7% | ||
| Q2 25 | 49.2% | -47.0% | ||
| Q1 25 | 51.5% | -38.4% | ||
| Q4 24 | — | -52.7% | ||
| Q3 24 | — | -3.5% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | — | 2.8% |
净利率CRMDRGP
| Q4 25 | — | -10.8% | ||
| Q3 25 | 104.1% | -2.0% | ||
| Q2 25 | 49.9% | -52.6% | ||
| Q1 25 | 52.8% | -34.0% | ||
| Q4 24 | — | -47.2% | ||
| Q3 24 | — | -4.2% | ||
| Q2 24 | — | 7.1% | ||
| Q1 24 | — | 1.7% |
每股收益（稀释后）CRMDRGP
| Q4 25 | $0.20 | $-0.38 | ||
| Q3 25 | $1.26 | $-0.07 | ||
| Q2 25 | $0.28 | $-2.21 | ||
| Q1 25 | $0.30 | $-1.34 | ||
| Q4 24 | — | $-2.08 | ||
| Q3 24 | — | $-0.17 | ||
| Q2 24 | — | $0.31 | ||
| Q1 24 | — | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $148.5M | $89.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $405.3M | $194.6M |
| 总资产 | $826.1M | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRMDRGP
| Q4 25 | $148.5M | $89.8M | ||
| Q3 25 | $55.7M | $77.5M | ||
| Q2 25 | $190.7M | $86.1M | ||
| Q1 25 | $77.5M | $72.5M | ||
| Q4 24 | — | $78.2M | ||
| Q3 24 | — | $89.6M | ||
| Q2 24 | — | $108.9M | ||
| Q1 24 | — | $113.8M |
股东权益CRMDRGP
| Q4 25 | $405.3M | $194.6M | ||
| Q3 25 | $374.1M | $206.4M | ||
| Q2 25 | $220.6M | $207.1M | ||
| Q1 25 | $114.9M | $277.8M | ||
| Q4 24 | — | $325.7M | ||
| Q3 24 | — | $407.2M | ||
| Q2 24 | — | $418.8M | ||
| Q1 24 | — | $414.9M |
总资产CRMDRGP
| Q4 25 | $826.1M | $289.3M | ||
| Q3 25 | $750.9M | $287.2M | ||
| Q2 25 | $252.6M | $304.7M | ||
| Q1 25 | $149.6M | $375.6M | ||
| Q4 24 | — | $424.9M | ||
| Q3 24 | — | $512.9M | ||
| Q2 24 | — | $510.9M | ||
| Q1 24 | — | $523.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $94.5M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $92.7M | $15.6M |
| 自由现金流率自由现金流/营收 | 72.1% | 13.2% |
| 资本支出强度资本支出/营收 | 1.3% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $172.8M | $24.3M |
8季度趋势，按日历期对齐
经营现金流CRMDRGP
| Q4 25 | $94.5M | $15.9M | ||
| Q3 25 | $30.9M | $-7.8M | ||
| Q2 25 | $30.0M | $16.8M | ||
| Q1 25 | $19.7M | $659.0K | ||
| Q4 24 | — | $1.8M | ||
| Q3 24 | — | $-309.0K | ||
| Q2 24 | — | $3.2M | ||
| Q1 24 | — | $20.5M |
自由现金流CRMDRGP
| Q4 25 | $92.7M | $15.6M | ||
| Q3 25 | $30.4M | $-8.0M | ||
| Q2 25 | $30.0M | $16.5M | ||
| Q1 25 | $19.7M | $238.0K | ||
| Q4 24 | — | $61.0K | ||
| Q3 24 | — | $-575.0K | ||
| Q2 24 | — | $3.0M | ||
| Q1 24 | — | $20.4M |
自由现金流率CRMDRGP
| Q4 25 | 72.1% | 13.2% | ||
| Q3 25 | 29.1% | -6.6% | ||
| Q2 25 | 75.4% | 11.8% | ||
| Q1 25 | 50.5% | 0.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | 13.5% |
资本支出强度CRMDRGP
| Q4 25 | 1.3% | 0.3% | ||
| Q3 25 | 0.5% | 0.1% | ||
| Q2 25 | 0.1% | 0.2% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
现金转化率CRMDRGP
| Q4 25 | — | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | — | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRMD
| Acquisition Of Melinta | $52.9M | 41% |
| Melinta Portfolio | $45.5M | 35% |
| Other | $18.6M | 14% |
| Contract Revenue | $7.4M | 6% |
| BARDA Agreement | $4.2M | 3% |
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
